Trade ProShares VIX Mid-Term Futures ETF - VIXM CFD

Trading Conditions

• Type: CFD
• Spread: 0.12
• Long position overnight funding adjustment: -0.02149%
• Short position overnight funding adjustment: -0.00074%
• Overnight funding adjustment time: 21:00 (UTC)
• Currency: USD
• Min traded quantity: 1
• Margin: 5.00%
• Stock exchange: United States of America
• Commission on trade: 0%
• Guaranteed stop premium: 1%

Key Stats

• Prev. Close: 16.57
• Open: 16.7
• 1-Year Change: 9.72%
• Day's Range: 16.6 - 16.82

What is ProShares VIX Mid-Term Futures ETF (VIXM)?

ProShares VIX Mid-Term Futures ETF is an exchange-traded fund that seeks to provide investment results corresponding to the performance of the S&P 500 VIX Mid-Term Futures Index. This index reflects the market's expectation of volatility over a mid-term horizon, based on futures contracts on the CBOE Volatility Index (VIX). The fund is designed for investors seeking exposure to volatility as an asset class, often used for hedging or diversification purposes. Managed by ProShares, it offers a way to gain access to volatility futures without directly trading futures contracts.

ProShares VIX Mid-Term Futures ETF Stock Price Today: Live Overview

The price today is shaped by market fluctuations as ProShares VIX Mid-Term Futures ETF trades at $16.86. It has moved within a daily range of $16.54 to $16.82, with an overall percentage change of +0.9644%.

FAQ: ProShares VIX Mid-Term Futures ETF (VIXM)

What is the current price of VIXM stock?

The current price is $16.86.

Does VIXM pay dividends?

Dividends are paid by this ETF.

Does VIXM have a formal corporate presence or regional headquarters in the UAE?

There is no official office or subsidiary of the company in the UAE; operations are conducted via partners and distributors.

What is VIXM best known for?

This ETF is most famous for providing exposure to mid-term VIX futures contracts.

What assets are typically shown together with VIXM?

Commonly shown alongside VIXM: American Airlines Group Inc, Alimentation Couche-Tard Inc, ProShares UltraShort Nasdaq Biotechnology